Orchid Pharma Limited (BOM:524372)

Orchid Pharma Statistics

Total Valuation

Orchid Pharma has a market cap or net worth of INR 39.60 billion. The enterprise value is 38.81 billion.

Market Cap	39.60B
Enterprise Value	38.81B

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	50.72M
Shares Outstanding	n/a
Shares Change (YoY)	+10.51%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	15.19M

Valuation Ratios

The trailing PE ratio is 35.72 and the forward PE ratio is 28.65.

PE Ratio	35.72
Forward PE	28.65
PS Ratio	4.39
PB Ratio	3.23
P/TBV Ratio	3.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	35.00
EV / Sales	4.31
EV / EBITDA	38.75
EV / EBIT	45.50
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.13
Debt / EBITDA	1.65
Debt / FCF	n/a
Interest Coverage	6.04

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	4.02%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	10.35M
Profits Per Employee	1.27M
Employee Count	871
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.71%
50-Day Moving Average	817.44
200-Day Moving Average	1,302.95
Relative Strength Index (RSI)	43.80
Average Volume (20 Days)	6,071

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orchid Pharma had revenue of INR 9.02 billion and earned 1.11 billion in profits. Earnings per share was 21.87.

Revenue	9.02B
Gross Profit	3.48B
Operating Income	851.15M
Pretax Income	1.08B
Net Income	1.11B
EBITDA	996.32M
EBIT	851.15M
Earnings Per Share (EPS)	21.87

Balance Sheet

The company has 2.44 billion in cash and 1.65 billion in debt, giving a net cash position of 789.49 million.

Cash & Cash Equivalents	2.44B
Total Debt	1.65B
Net Cash	789.49M
Net Cash Per Share	n/a
Equity (Book Value)	12.24B
Book Value Per Share	241.38
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 38.66%, with operating and profit margins of 9.44% and 12.30%.

Gross Margin	38.66%
Operating Margin	9.44%
Pretax Margin	11.94%
Profit Margin	12.30%
EBITDA Margin	11.05%
EBIT Margin	9.44%
FCF Margin	n/a

Dividends & Yields

Orchid Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.51%
Shareholder Yield	-10.51%
Earnings Yield	2.80%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a